DEA schedule
Is estradiol a controlled substance?
Federal schedule for estradiol from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Estradiol is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and estradiol is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted estradiol?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 258 prescription listings from 47 labelers, none with a DEA schedule |
| DEA controlled substances list | estradiol is not on the list |
Estradiol NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 50419-454 | Climara | patch | .025 mg/d | Bayer HealthCare Pharmaceuticals Inc. | None |
| 50419-456 | Climara | patch | .0375 mg/d | Bayer HealthCare Pharmaceuticals Inc. | None |
| 50419-451 | Climara | patch | .05 mg/d | Bayer HealthCare Pharmaceuticals Inc. | None |
| 50419-459 | Climara | patch | .06 mg/d | Bayer HealthCare Pharmaceuticals Inc. | None |
| 50419-453 | Climara | patch | .075 mg/d | Bayer HealthCare Pharmaceuticals Inc. | None |
| 50419-452 | Climara | patch | .1 mg/d | Bayer HealthCare Pharmaceuticals Inc. | None |
| 68025-065 | DIVIGEL | gel | .25 mg/.25g | Vertical Pharmaceuticals, LLC | None |
| 68025-066 | DIVIGEL | gel | .5 mg/.5g | Vertical Pharmaceuticals, LLC | None |
| 68025-083 | DIVIGEL | gel | .75 mg/.75g | Vertical Pharmaceuticals, LLC | None |
| 68025-067 | DIVIGEL | gel | 1 mg/g | Vertical Pharmaceuticals, LLC | None |
| 68025-086 | DIVIGEL | gel | 1.25 mg/1.25g | Vertical Pharmaceuticals, LLC | None |
| 0037-4801 | ELESTRIN | gel, metered | .52 mg/.87g | Viatris Specialty LLC | None |
| 13811-090 | Estradiol | gel | .25 mg/.25g | Trigen Laboratories, LLC | None |
| 13811-091 | Estradiol | gel | .5 mg/.5g | Trigen Laboratories, LLC | None |
| 13811-092 | Estradiol | gel | .75 mg/.75g | Trigen Laboratories, LLC | None |
| 13811-093 | Estradiol | gel | 1 mg/g | Trigen Laboratories, LLC | None |
| 13811-094 | Estradiol | gel | 1.25 mg/1.25g | Trigen Laboratories, LLC | None |
| 0013-1042 | Estring | system | 2 mg/1 | Pfizer Laboratories Div Pfizer Inc | None |
| 17139-617 | EstroGel | gel, metered | .75 mg/1.25g | ASCEND Therapeutics US, LLC | None |
| 0574-2067 | Evamist | spray | 1.53 mg/1 | Padagis US LLC | None |
| 50419-455 | Menostar | patch | 14 ug/d | Bayer HealthCare Pharmaceuticals Inc. | None |
| 68968-6625 | Minivelle | film, extended release | .025 mg/d | Noven Therapeutics, LLC | None |
| 68968-6637 | Minivelle | film, extended release | .0375 mg/d | Noven Therapeutics, LLC | None |
| 68968-6650 | Minivelle | film, extended release | .05 mg/d | Noven Therapeutics, LLC | None |
| 68968-6675 | Minivelle | film, extended release | .075 mg/d | Noven Therapeutics, LLC | None |
| 68968-6610 | Minivelle | film, extended release | .1 mg/d | Noven Therapeutics, LLC | None |
| 0169-5176 | Vagifem | insert | 10 ug/1 | Novo Nordisk | None |
| 66758-145 | Vivelle-Dot | patch, extended release | .025 mg/d | Sandoz Inc | None |
| 66758-146 | Vivelle-Dot | patch, extended release | .0375 mg/d | Sandoz Inc | None |
| 66758-147 | Vivelle-Dot | patch, extended release | .05 mg/d | Sandoz Inc | None |
| 66758-148 | Vivelle-Dot | patch, extended release | .075 mg/d | Sandoz Inc | None |
| 66758-149 | Vivelle-Dot | patch, extended release | .1 mg/d | Sandoz Inc | None |
| 65162-989 | DOTTI | patch, extended release | .025 mg/d | Amneal Pharmaceuticals LLC | None |
| 72162-2032 | DOTTI | patch, extended release | .025 mg/d | Bryant Ranch Prepack | None |
| 65162-992 | DOTTI | patch, extended release | .0375 mg/d | Amneal Pharmaceuticals LLC | None |
| 72162-2033 | DOTTI | patch, extended release | .0375 mg/d | Bryant Ranch Prepack | None |
| 65162-993 | DOTTI | patch, extended release | .05 mg/d | Amneal Pharmaceuticals LLC | None |
| 72162-2034 | DOTTI | patch, extended release | .05 mg/d | Bryant Ranch Prepack | None |
| 65162-995 | DOTTI | patch, extended release | .075 mg/d | Amneal Pharmaceuticals LLC | None |
| 72162-2035 | DOTTI | patch, extended release | .075 mg/d | Bryant Ranch Prepack | None |
Showing 40 of 258 listings.
Questions
Is estradiol a controlled substance?
No. Estradiol is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and estradiol is not on the DEA controlled substances list.
Is estradiol a narcotic?
No. Estradiol is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Estrogen.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Estradiol
- What is Estradiol used for?FDA label uses
- Generic for AloraFDA Orange Book
- Generic for ClimaraFDA Orange Book
- Generic for FempatchFDA Orange Book
- Generic for MinivelleFDA Orange Book
- Generic for ElestrinFDA Orange Book
- Generic for EstroGelFDA Orange Book
- Generic for DivigelFDA Orange Book
- Generic for EstringFDA Orange Book
- Generic for ImvexxyFDA Orange Book
- Generic for EvamistFDA Orange Book
- Generic for EsclimFDA Orange Book
- Generic for EstradermFDA Orange Book
- What is Yuvafem used for?FDA label uses
- Is Yuvafem a controlled substance?Federal schedule
- What is Dotti used for?FDA label uses